News

Elanco Animal Health said it has received marketing authorization for Zenrelia, a dermatology treatment for dogs, from the European Commission. The animal health products and services provider said ...
Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...
Summer weather can make you feel hot and sweaty, but for your dog, this season can be when allergies start to flare, ...
CHICO, Calif. - Arthritis is a leading reason for euthanizing older pets, but a new treatment called Synovetin OA is offering hope to pet owners. This breakthrough is promising to change the lives of ...
Dogs' noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect ...
An evidence-based lecture at the 2025 AVMA Convention breaks down study findings on various strain-specific probiotics in ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.
FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough Doc Louallen, ABC News Jul 10, 2025 | 4:28 PM STOCK PHOTO/Getty Images (WASHINGTON) — Dogs across the U.S. could soon get ...
FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough New treatment offers dogs year-round protection with a single shot.
These dogs will often struggle with painful swallowing, decreased appetite, neck sensitivity, and holding their head and neck in an abnormal position. Esophageal irritation often requires veterinary ...
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.